-
Bristol-Myers Squibb Files Lawsuit Against US Agency For Overreach In 340B Drug Pricing Program
Friday, November 29, 2024 - 1:37pm | 525Bristol-Myers Squibb Co (NYSE:BMY) filed a lawsuit on Tuesday against the U.S. Health Resources and Services Administration (HRSA) and the U.S. Department of Health and Human Services (HHS), alleging that HRSA's rejection of its proposed rebate model for the 340B Drug Pricing Program violates...
-
Mounjaro-Maker Eli Lilly Files Lawsuit Against US Agency Over Drug Rebate Program
Friday, November 15, 2024 - 6:02am | 532Eli Lilly And Co. (NYSE:LLY) has filed a lawsuit against the Health Resources and Services Administration (HRSA). The pharmaceutical giant claims that HRSA obstructed its attempt to alter drug discount offerings to hospitals. What Happened: As per Eli Lilly’s official statement on Thursday,...